首页> 美国卫生研究院文献>The Scientific World Journal >Biomarker Identification for Prostate Cancer and Lymph Node Metastasis from Microarray Data and Protein Interaction Network Using Gene Prioritization Method
【2h】

Biomarker Identification for Prostate Cancer and Lymph Node Metastasis from Microarray Data and Protein Interaction Network Using Gene Prioritization Method

机译:使用基因优先排序方法从微阵列数据和蛋白质相互作用网络中鉴定前列腺癌和淋巴结转移的生物标志物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Finding a genetic disease-related gene is not a trivial task. Therefore, computational methods are needed to present clues to the biomedical community to explore genes that are more likely to be related to a specific disease as biomarker. We present biomarker identification problem using gene prioritization method called gene prioritization from microarray data based on shortest paths, extended with structural and biological properties and edge flux using voting scheme (GP-MIDAS-VXEF). The method is based on finding relevant interactions on protein interaction networks, then scoring the genes using shortest paths and topological analysis, integrating the results using a voting scheme and a biological boosting. We applied two experiments, one is prostate primary and normal samples and the other is prostate primary tumor with and without lymph nodes metastasis. We used 137 truly prostate cancer genes as benchmark. In the first experiment, GP-MIDAS-VXEF outperforms all the other state-of-the-art methods in the benchmark by retrieving the truest related genes from the candidate set in the top 50 scores found. We applied the same technique to infer the significant biomarkers in prostate cancer with lymph nodes metastasis which is not established well.
机译:寻找与遗传疾病相关的基因并不是一件容易的事。因此,需要计算方法来向生物医学界提供线索,以探索更可能与特定疾病相关的基因作为生物标记。我们提出了使用基因优先化方法(称为基因优先化)的生物标记物识别问题,该方法基于最短路径从微阵列数据中获得,并使用投票方案(GP-MIDAS-VXEF)扩展了结构和生物学特性以及边缘通量。该方法基于在蛋白质相互作用网络上找到相关的相互作用,然后使用最短路径和拓扑分析对基因进行评分,并使用投票方案和生物学促进对结果进行整合。我们应用了两个实验,一个是前列腺原发和正常样本,另一个是有和没有淋巴结转移的前列腺原发肿瘤。我们使用137个真正的前列腺癌基因作为基准。在第一个实验中,GP-MIDAS-VXEF通过从发现的前50个得分中的候选集中检索最真实的相关基因,从而胜过基准中所有其他最新技术。我们应用了相同的技术来推断前列腺癌伴淋巴结转移的重要生物标志物,但尚未确定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号